161 related articles for article (PubMed ID: 35429302)
41. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis.
Zhang Y; Gao J; Bao Y; Liu Y; Tong Y; Jin S; Zhao Q
Biomarkers; 2022 Feb; 27(1):13-21. PubMed ID: 34787036
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA BACE1-AS plays an oncogenic role in hepatocellular carcinoma cells through miR-214-3p/APLN axis.
Tian Q; Yan X; Yang L; Liu Z; Yuan Z; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1538-1546. PubMed ID: 34636395
[TBL] [Abstract][Full Text] [Related]
45. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
46. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Dong QZ; Zhang XF; Zhao Y; Jia HL; Zhou HJ; Dai C; Sun HJ; Qin Y; Zhang WD; Ren N; Ye QH; Qin LX
Hepatology; 2013 Mar; 57(3):1024-34. PubMed ID: 23079960
[TBL] [Abstract][Full Text] [Related]
47. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
[TBL] [Abstract][Full Text] [Related]
48. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
49. Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression.
Kang YS; Jeong EJ; Seok HJ; Kim SK; Hwang JS; Choi ML; Jo DG; Kim Y; Choi J; Lee YJ; Jung E; Min JK; Han TS; Kim JS
Biochem Biophys Res Commun; 2019 Jan; 508(1):275-281. PubMed ID: 30497779
[TBL] [Abstract][Full Text] [Related]
50. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
51. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
52. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
53. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach.
Yang Y; Ma Y; Yuan M; Peng Y; Fang Z; Wang J
Liver Int; 2021 Oct; 41(10):2485-2498. PubMed ID: 34033190
[TBL] [Abstract][Full Text] [Related]
54. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
[TBL] [Abstract][Full Text] [Related]
55. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
[TBL] [Abstract][Full Text] [Related]
56. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
Im E; Yeo C; Lee EO
Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
[TBL] [Abstract][Full Text] [Related]
57. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma.
Luo D; Zhang X; Li XK; Chen G
J Immunol Res; 2021; 2021():1801873. PubMed ID: 34423049
[TBL] [Abstract][Full Text] [Related]
58. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
60. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
Sun Q; Liu P; Long B; Zhu Y; Liu T
Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
